Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosis

Fig. 5

Immunotherapeutic responses in two subtypes. Notes: A The immune, stromal, and ESTIMATE scores were compared between two subtypes. B Patients in LM2 have a lower percentage of responders. C Subclass mapping analysis showed differences in response to PD1 treatment between patients in LM1 and LM2. D The predicted IC50 for 8 common chemo drugs was presented

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us